Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placeboSPN-820 was well-tolerated ...
Four regimens fail endpoints simultaneously in HEALEY ALS trial
ALS candidates from Biohaven, Prilenia, Clene and UCB have all failed to halt disease progression versus placebo in the ...
abc7NY1d
LI girl speaks out after clinical trial for Spinal Muscular Atrophy cut by President Trump
A girl on Long Island is speaking out after a clinical trial for Spinal Muscular Atrophy was cut by President Trump ...
Medpage Today on MSN5d
What's the Better Option for High-Risk Prostate Cancer -- Radiation or Surgery?
Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...
Agios’ Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint
ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...